Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - technology+classifications+%3e+human+health+care+%3e+therapeutics
100
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Septal Myectomy Retractor for Aiding Cardiac Surgeons in Treating Hypertrophic Obstructive Cardiomyopathy (HOCM)
Provides Surgeons Improved and Constant Visualization, Increasing the Efficiency, Precision, Safety, and Speed of the Operation This septal myectomy retractor improves the visualization, speed and safety of the septal myectomy procedure, resulting in a more successful surgical outcome. Hypertrophic obstructive cardiomyopathy (HOCM) is a congenital...
Published: 9/16/2024
|
Inventor(s):
Susan Cooke
Keywords(s):
Category(s):
Technology Classifications > Medical Devices > Equipment
,
Technology Classifications > Human Health Care > Therapeutics
Bacteriophage Composition for Treating Neurodegenerative Diseases
Combination Treatment of Bacteriophages and Probiotic to Remove Detrimental Bacteria from Host Gut, Remodeling Gut Microbiota and Preventing Toxic Protein Aggregation This therapeutic composition administers bacteriophages to eliminate specific bacterial strains that induce toxic protein aggregation and ultimately contribute to neurodegenerative protein...
Published: 8/19/2024
|
Inventor(s):
Daniel Czyz
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Therapeutics
,
Technology Classifications > Human Health Care > Nutraceutical
Broad Spectrum Antimicrobial Compounds for Countering Antibiotic-Resistant Bacteria
Provide a Number of Promising Starting Points for Developing New Classes of Antibiotics These molecular compounds have potent antibacterial activity against a broad spectrum of Gram-negative bacteria, have no structural similarity to known antibiotics, can be readily synthesized in a few steps, and have low cytotoxicity with mammalian cells. Antibiotic...
Published: 9/4/2024
|
Inventor(s):
Timothy Spicer
,
Louis Scampavia
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Therapeutics
,
Technology Classifications > Human Health Care > Others
Tissue-Specific Chimeric Constructs for Treating Duchenne Muscular Dystrophy
Delivers Micro-dystrophin and Utrophin Chimeric Constructs to the Skeletal and Cardiac Muscles, Optimizing the Gene Therapy to Each Tissue These micro-dystrophin and utrophin chimeric constructs optimize the treatment of Duchenne Muscular Dystrophy (DMD). DMD is a rare, X-chromosome-linked disorder characterized by progressive muscle degeneration and...
Published: 9/4/2024
|
Inventor(s):
Hugh Sweeney
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Therapeutics
,
Technology Classifications > Human Health Care > Gene Therapy
Recombinant AAV9 Vectors with Modified Capsids for Escaping Neutralizing Human Antibodies
Amino Acid Substitutions on the Capsid Surface to Evade Neutralizing Antibodies and Improve Gene Therapy Efficacy and Safety Adeno-associated virus (AAV)-based vectors are the leading platform for the delivery of gene therapy in vivo, but have a limitation in that they need to avoid neutralizing and potentially dangerous immune response to the AAV...
Published: 9/4/2024
|
Inventor(s):
Robert McKenna
,
Mario Mietzsch
,
Jane Hsi
,
Austin Nelson
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Gene Therapy
,
Technology Classifications > Human Health Care > Therapeutics
YAP-TEAD Core Inhibitors for Developing Cancer Therapeutics
Inhibit YAP-TEAD Interactions for the Treatment of Diseases with Altered Hippo Signaling These small molecule inhibitors target TEA domain (TEAD) proteins, with the potential to treat diseases with altered Hippo signaling, such as Hepatocellular Carcinoma (HCC) and Hepatoblastoma (HB). The Hippo signaling pathway is vital to organ growth control, stem...
Published: 9/3/2024
|
Inventor(s):
Chenglong Li
,
Chen Zhou
,
Liya Pi
,
Chunbao Sun
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Therapeutics
Oxygen-Generating and Free Radical Scavenging Wound Dressing
Stimulates Tissue Repair by Providing Sustained Release of Oxygen and Combating Oxidative Damage This oxygen-generating and free radical scavenging biomaterial facilitates chronic wound healing, particularly diabetic foot ulcers (DFUs). This direct oxygen supply promotes cell growth and tissue repair, as well as neutralizes harmful free radicals, accelerating...
Published: 9/3/2024
|
Inventor(s):
Cherie Stabler
,
Jiapu Liang
,
Nicholas Abuid
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Therapeutics
Deep Brain Stimulation Algorithm and Tool for Optimized Treatment of Movement Disorders
Predicts Personalized Stimulation Parameters in Real Time by Direct Sensing of the Patient’s Brain This therapeutic algorithm and tool processes neural signals to determine optimal and personalized deep brain stimulation (DBS) to treat and reduce symptoms of movement disorders. Deep brain stimulation (DBS) is an invasive neurological therapy...
Published: 9/3/2024
|
Inventor(s):
Coralie de Hemptinne
,
Jackson Cagle
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Therapeutics
Droplet-Based Electroporation for High-Throughput Biomolecular Cargo Loading of Extracellular Vesicles and Exosomes
Optimizes Cargo Loading a Sub-Cellular Scale, Enabling the Scaling of Drug Manufacturing This electroporation platform enables the efficient, large-scale loading of biomolecular cargo into extracellular vesicles (EVs) and exosomes. Extracellular vesicles (EVs) are biocompatible, have fast cellular uptake, and can penetrate biological barriers, making...
Published: 4/1/2024
|
Inventor(s):
Mei He
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Therapeutics
,
Technology Classifications > Human Health Care > Drug Delivery
Atheliapyrrolidine A, a Serotonin Receptor Antagonist for Treating Psychotic Disorders
Produces 5-HT2A Receptor Antagonism in a Subject, Enabling the Development of Potential Antipsychotic and/or Antischizophrenic Treatments This compound, Atheliapyrrolidine A, produces 5-HT2A receptor antagonism for treating psychiatric disorders. The 5-HT2A receptor (5-HT2AR) is one of 14 genetically encoded 5-HT serotonin receptors in humans. Antagonists...
Published: 9/3/2024
|
Inventor(s):
Sandra Loesgen
,
Annika Jagels
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Therapeutics
,
Technology Classifications > Engineering > Chemical
1
2
3
4
5
6
7
8
9
10